Thomas Exner

Title: Innovations by Thomas Exner

Introduction

Thomas Exner is an accomplished inventor based in Gordon, Australia. He has made significant contributions to the field of medical technology, particularly in the area of coagulation testing. With a total of 3 patents to his name, Exner's work has the potential to enhance diagnostic capabilities in clinical settings.

Latest Patents

One of Exner's latest patents is a method for determining the coagulation potential of a plasma sample. This innovative method involves pre-incubating the plasma sample with a reagent that partially converts endogenous protein C into activated protein C. The process includes adding factor Xa, which is progressively inactivated by antithrombin III/heparin cofactor 2 during preincubation. An exogenous reagent is then added to activate factor X to Xa or prothrombin to thrombin in a factor V-dependent manner. The reaction is monitored to determine the rate of coagulation, which is compared to control rates to assess the coagulation potential of the plasma sample.

Another notable patent by Exner is the activated protein C resistance test. This test is crucial for evaluating coagulation disorders and has significant implications for patient care.

Career Highlights

Exner is associated with Gradipore Limited, a company that focuses on innovative medical technologies. His work at Gradipore has allowed him to develop and refine his patented methods, contributing to advancements in coagulation testing.

Conclusion

Thomas Exner's contributions to medical technology through his patents demonstrate his commitment to improving diagnostic methods in healthcare. His innovative approaches have the potential to significantly impact patient outcomes in coagulation management.